John Overdeck’s Hologic HOLX Stock Holding History

John Overdeck’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,900	Closed	-$861K	–	4438
2021 Q2	$861K	Buy	12,900 +8,600	+200%	+$575K	﹤0.01%	2611
2021 Q1	$320K	Buy	4,300 +500	+13%	+$38K	﹤0.01%	3275
2020 Q4	$277K	Buy	+3,800	New	+$268K	﹤0.01%	2925
2018 Q4	–	Sell	-10,000	Closed	-$410K	–	3208
2018 Q3	$410K	Buy	+10,000	New	+$404K	﹤0.01%	2585
2018 Q2	–	Sell	-61,200	Closed	-$2.29M	–	3445
2018 Q1	$2.29M	Buy	61,200 +51,600	+538%	+$2.09M	0.01%	1433
2017 Q4	$410K	Buy	+9,600	New	+$383K	﹤0.01%	2565

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

John Overdeck's HOLX Position: Q2 2026 in Review

John Overdeck sold out of Hologic (HOLX) in Q2 2026, closing a stake of 328,504 shares — an estimated $24.8M sold.

John Overdeck first reported a position in HOLX in Q3 2013 and held it in 46 quarters. The position peaked at $60.2M in Q4 2015. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

John Overdeck reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
John Overdeck sold 328,504 Hologic shares in Q2 2026, an estimated $24.8M.
John Overdeck first reported a position in Hologic in Q3 2013 and held it in 46 quarters.
John Overdeck's Hologic position peaked at $60.2M in Q4 2015.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.